DocuSign, Inc. director Rowan M. Trollope filed a Form 4 on November 3, 2026, disclosing the vesting of 870 restricted stock units into common stock on November 2, 2026.

Key Highlights

  • Reporting person: Rowan M. Trollope, listed as a director of DocuSign, Inc. (NASDAQ:DOCU)
  • Transaction: 870 restricted stock units (RSUs) vested and were acquired as common stock on November 2, 2026, at a price of $0
  • Post-transaction common stock ownership: 1,739 shares held directly following the transaction
  • Remaining RSUs: 8,699 RSUs remain beneficially owned directly after the reported transaction
  • Vesting schedule: RSUs vest in twelve equal quarterly installments over three years, with a vesting commencement date of May 2, 2026, subject to continued service
  • RSU terms: Each RSU represents a contingent right to receive one share of common stock; RSUs do not expire but are either vested or canceled prior to vesting

DocuSign Director Trollope's RSU Vesting: Transaction Details

According to the Form 4 filed with the SEC on November 3, 2026, Rowan M. Trollope, a director of DocuSign, Inc. (NASDAQ:DOCU), reported a transaction coded "M" on November 2, 2026. The transaction involved the acquisition of 870 shares of common stock upon the vesting of 870 RSUs, at a reported price of $0 per unit. Following this transaction, Trollope directly held 1,739 shares of DocuSign common stock.

The filing discloses that each RSU represents a contingent right to receive one share of the issuer's common stock. The RSUs vest in twelve equal quarterly installments over three years, with a vesting commencement date of May 2, 2026, in each case subject to the reporting person being a service provider through each such vesting date. The filing further notes that "the RSUs do not expire; they either vest or are canceled prior to vesting date."

After the reported vesting event, the filing states that Trollope beneficially owned 8,699 RSUs directly in Table II, reflecting the remaining unvested portion of the original grant. The Form 4 was signed by Derrick Chapman as attorney-in-fact on November 3, 2026.

What Was Disclosed

The filing reports the vesting of 870 RSUs into 870 shares of DocuSign common stock by director Rowan M. Trollope on November 2, 2026, leaving 8,699 RSUs and 1,739 shares of common stock held directly after the transaction.